This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Janssen Biotech, Inc.. Active years: 2020-2021.
Location History:
- Spring House, PA (US) (2020)
- Blue Bell, PA (US) (2021)
Company Filing History:
Years Active: 2020-2021
Title: Innovations by Kamyar Farahi in Psoriasis Treatment
Introduction
Kamyar Farahi is an accomplished inventor based in Blue Bell, PA (US). He has made significant contributions to the field of medicine, particularly in the treatment of IL-12/23-related diseases. With a total of two patents to his name, Farahi's work is paving the way for innovative therapeutic approaches.
Latest Patents
Farahi's latest patents focus on methods of treating psoriatic arthritis and psoriasis using increased interval dosing of anti-IL12/23 antibodies. The first patent describes a method for treating psoriatic arthritis by administering the antibody initially and then at intervals of 4 weeks, 16 weeks, and 28 weeks, with an increased dosing interval thereafter. The second patent outlines a similar approach for treating psoriasis, emphasizing the importance of adjusting the dosing schedule to enhance patient outcomes.
Career Highlights
Kamyar Farahi is currently associated with Janssen Biotech, Inc., where he continues to innovate in the field of immunology. His work is characterized by a commitment to improving treatment protocols for patients suffering from chronic conditions.
Collaborations
Farahi collaborates with notable colleagues, including Marc Chevrier and Newman Yeilding, to advance research and development in his field. Their combined expertise contributes to the success of their projects and the impact of their innovations.
Conclusion
Kamyar Farahi's contributions to the treatment of IL-12/23-related diseases highlight the importance of innovative approaches in medicine. His patents reflect a dedication to improving patient care through advanced therapeutic methods.